Medicare billing address
CMS Medicare provider billing file
30 W Mccreight AveSuite 110
Springfield, OH 45504
CMS public data · NPI 1124231154
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Shannon C Trotter, D.O.
Specialty
Credential
D.O.
NPI
1124231154
Primary source state
OH
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Shannon C Trotter, D.O. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
30 W Mccreight AveCMS Doctors & Clinicians file
187 S Tuttle RdCMS Doctors & Clinicians file
5300 Far Hills AveCMS Doctors & Clinicians file
6365 Winchester BlvdIn the 2024 CMS provider billing file, this NPI had 767 Medicare beneficiaries and 5,649 total services. The average beneficiary age was 74, and the average HCC risk score was 0.9.
Total Medicare allowed amount
$442,321.19
Total Medicare payment amount
$319,039.85
Medicare beneficiaries
767
Total services
5,649
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
71%
CMS beneficiary-panel share
Ischemic heart disease
23%
CMS beneficiary-panel share
Diabetes
22%
CMS beneficiary-panel share
Anxiety
22%
CMS beneficiary-panel share
Mood disorders
20%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,784 | $5.99 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 675 | $85.18 |
| Destruction of precancer skin growth, 1 growth | 489 | $46.95 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 395 | $120.45 |
| Biopsy of related skin growth, first growth | 312 | $79.80 |
| Destruction of skin growth, 1-14 growths | 304 | $100.92 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 140 | $388.43 |
| Application of light with debridement to destroy precancer skin growth | 120 | $250.73 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 101 | $0.95 |
| Biopsy of related skin growth, each additional growth | 95 | $45.72 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1124231154. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Triamcinolone Acetonide | Triamcinolone Acetonide | 439 | 484.5 | $4,871.85 |
| 2 | Ketoconazole | Ketoconazole | 311 | 338.2 | $3,227.36 |
| 3 | Ciclopirox | Ciclopirox Olamine | 171 | 204.3 | $4,039.44 |
| 4 | Fluocinonide | Fluocinonide | 125 | 143.5 | $6,276.37 |
| 5 | Mupirocin | Mupirocin | 123 | 123.5 | $677.39 |
| 6 | Clobetasol Propionate | Clobetasol Propionate | 91 | 93.3 | $3,946.64 |
| 7 | Doxycycline Hyclate | Doxycycline Hyclate | 87 | 95 | $1,615.51 |
| 8 | Minoxidil | Minoxidil | 80 | 116 | $579.94 |
| 9 | Ammonium Lactate | Ammonium Lactate | 74 | 90.7 | $1,476.80 |
| 10 | Fluorouracil | Fluorouracil | 65 | 66.1 | $4,498.10 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
Ohio University, College Of Osteopathic Medicine
Graduation year
2006
Group/practice field
Dermatologists Of Southwestern Ohio, Llc
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.